{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:00:16Z","timestamp":1790409616469,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00272815"],"award-info":[{"award-number":["RS-2023-00272815"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00406114"],"award-info":[{"award-number":["RS-2024-00406114"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00517908"],"award-info":[{"award-number":["RS-2025-00517908"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioactmat.2026.04.025","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:12:09Z","timestamp":1777601529000},"page":"135-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GSH-responsive nanovaccine triggers immunogenic cell death and potent memory T cell immunity for durable, recurrence-free tumor eradication"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-0490","authenticated-orcid":false,"given":"Khang-Yen","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1181-4519","authenticated-orcid":false,"given":"Thu Huyen Le","family":"Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3246-2520","authenticated-orcid":false,"given":"Anil","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongjun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeg Kyu","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-169X","authenticated-orcid":false,"given":"Jee-Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.04.025_bib1","article-title":"Recent advances in nanomodulators for augmenting cancer immunotherapy in cold tumors: insights from drug delivery to drug-free strategies","volume":"34","author":"Zhang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib5","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41401-022-00910-w","article-title":"Engineered nanomedicines block the PD-1\/PD-L1 axis for potentiated cancer immunotherapy","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106550","article-title":"Intelligent delivery system targeting PD-1\/PD-L1 pathway for cancer immunotherapy","volume":"136","author":"Liu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s44222-022-00016-2","article-title":"Targeted modulation of immune cells and tissues using engineered biomaterials","volume":"1","author":"Yousefpour","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41401-022-00953-z","article-title":"Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights","volume":"44","author":"Ni","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib12","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib13","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1021\/acsnano.2c11691","article-title":"Boosting checkpoint immunotherapy with biomaterials","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2020.07.004","article-title":"Clinical challenges of immune checkpoint inhibitors","volume":"38","author":"de Miguel","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib16","doi-asserted-by":"crossref","first-page":"11900","DOI":"10.1021\/acsnano.4c15442","article-title":"Galloylated toll-like receptor 7\/8 agonist nanovaccine for enhanced tumor antigen delivery in personalized immunotherapy","volume":"19","author":"Ma","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib17","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/acs.accounts.0c00313","article-title":"Nanoscale metal\u2013organic frameworks for cancer immunotherapy","volume":"53","author":"Ni","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41401-020-0400-z","article-title":"Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy","volume":"41","author":"Gao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jconrel.2023.02.015","article-title":"Vaccine-like nanomedicine for cancer immunotherapy","volume":"355","author":"Yi","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2023.02.016","article-title":"Nanotechnology for next-generation cancer immunotherapy: state of the art and future perspectives","volume":"356","author":"Chen","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib22","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.accounts.0c00456","article-title":"Engineered nanoparticles for cancer vaccination and immunotherapy","volume":"53","author":"Aikins","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-025-01952-x","article-title":"A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy","author":"You","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib25","article-title":"Stimuli-responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nantod.2019.04.005","article-title":"Designing inorganic nanomaterials for vaccines and immunotherapies","volume":"27","author":"Hess","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib27","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1039\/D3CS00673E","article-title":"Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications","volume":"53","author":"Wu","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113984","article-title":"In situ antigen-capture strategies for enhancing dendritic cell-mediated anti-tumor immunity","volume":"385","author":"Zheng","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41573-024-00974-9","article-title":"Enhancing in situ cancer vaccines using delivery technologies","volume":"23","author":"Gong","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib31","first-page":"612","article-title":"Turning foes to friends: advanced \u201cin situ nanovaccine\u201d with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer","volume":"39","author":"Wang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210385120","article-title":"Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination","volume":"120","author":"Wan","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41578-023-00617-2","article-title":"Responsive biomaterials: optimizing control of cancer immunotherapy","volume":"9","author":"Xue","year":"2024","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib35","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","article-title":"Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the Horizons in cancer treatment","volume":"15","author":"Gao","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215027","article-title":"Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment","volume":"480","author":"Fan","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib37","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1039\/C9CS00773C","article-title":"Molecular and nanoengineering approaches towards activatable cancer immunotherapy","volume":"49","author":"Zhang","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib39","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.apsb.2024.03.022","article-title":"Engineering nanomedicines for immunogenic eradication of cancer cells: recent trends and synergistic approaches","volume":"14","author":"Elzoghby","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300204","article-title":"Biomaterials that induce immunogenic cell death","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/anie.201804882","article-title":"Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy","volume":"58","author":"Duan","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nri.2017.9","article-title":"Dying cells actively regulate adaptive immune responses","volume":"17","author":"Yatim","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib46","article-title":"A forward vision for chemodynamic therapy: issues and opportunities","volume":"62","author":"Zhao","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib47","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1038\/s41467-024-48319-9","article-title":"Critical learning from industrial catalysis for nanocatalytic medicine","volume":"15","author":"Jin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202103868","article-title":"Chemodynamic therapy via fenton and fenton-like nanomaterials: strategies and recent advances","volume":"18","author":"Jia","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib49","doi-asserted-by":"crossref","first-page":"20400","DOI":"10.1021\/acsnano.2c06646","article-title":"Tumor microenvironment-activable manganese-boosted catalytic immunotherapy combined with PD-1 checkpoint blockade","volume":"16","author":"Zhao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib50","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/acsnano.1c08619","article-title":"Nanotransferrin-based programmable catalysis mediates three-pronged induction of oxidative stress to enhance cancer immunotherapy","volume":"16","author":"Bai","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib51","doi-asserted-by":"crossref","first-page":"15471","DOI":"10.1021\/acsnano.2c08013","article-title":"Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib52","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1002\/anie.202005111","article-title":"MnOx nanospikes as nanoadjuvants and immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect","volume":"59","author":"Ding","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202104223","article-title":"Manipulating intratumoral fenton chemistry for enhanced chemodynamic and chemodynamic-synergized multimodal therapy","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib54","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1002\/anie.201712027","article-title":"Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-Based nanoagent to enhance chemodynamic therapy","volume":"57","author":"Lin","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib55","article-title":"Boosting antitumor immunity via a tumor microenvironment-responsive transformable trifecta nanovaccine","volume":"34","author":"Li","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101222","article-title":"A redox-responsive nanovaccine combined with A2A receptor antagonist for cancer immunotherapy","volume":"10","author":"Yan","year":"2021","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib57","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1021\/acsnano.4c01229","article-title":"Genetically edited Cascade nanozymes for cancer immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib58","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1021\/acsnano.2c10352","article-title":"Biomineralized MnO2 nanoplatforms mediated delivery of immune checkpoint inhibitors with STING pathway activation to potentiate cancer radio-immunotherapy","volume":"17","author":"Deng","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201905823","article-title":"Manganese oxide nanomaterials: synthesis, properties, and theranostic applications","volume":"32","author":"Ding","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib60","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","article-title":"Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib61","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.actbio.2021.03.048","article-title":"Multi-stimuli responsive hollow MnO2-based drug delivery system for magnetic resonance imaging and combined chemo-chemodynamic cancer therapy","volume":"126","author":"Xu","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib62","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1021\/acsanm.2c01877","article-title":"Hollow MnO2 nanoparticles loaded with functional genes as nanovaccines for synergistic cancer therapy","volume":"5","author":"Wang","year":"2022","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib63","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1038\/s41467-024-53010-0","article-title":"Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41565-022-01296-w","article-title":"A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion","volume":"18","author":"Jin","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib65","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41467-021-22311-z","article-title":"Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors","volume":"12","author":"Bahmani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib66","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes","volume":"8","author":"Wang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121911","article-title":"T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer","volume":"291","author":"Duwa","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib68","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41467-019-09760-3","article-title":"Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice","volume":"10","author":"Yue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib69","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib70","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/s41467-022-31044-6","article-title":"Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib71","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1039\/D0CS00718H","article-title":"Engineering nanomedicine for glutathione depletion-augmented cancer therapy","volume":"50","author":"Xiong","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib73","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib74","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib75","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib76","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib77","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1073\/pnas.0909945107","article-title":"CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses","volume":"107","author":"Obar","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib79","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2164\/jandrol.111.015164","article-title":"A possible role for perforin and granzyme B in resveratrol-enhanced radiosensitivity of prostate cancer","volume":"33","author":"Fang","year":"2012","journal-title":"J. Androl."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib80","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41565-024-01781-4","article-title":"Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies","volume":"19","author":"Zhu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib81","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1021\/acsnano.3c05011","article-title":"Engineered selenium\/human serum albumin nanoparticles for efficient targeted treatment of parkinson's disease via oral gavage","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib82","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib83","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s43018-023-00588-x","article-title":"The landscape of T cell antigens for cancer immunotherapy","volume":"4","author":"Peri","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib84","first-page":"345","article-title":"STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy","volume":"42","author":"Nguyen","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/imr.13081","article-title":"Osteopontin\/secreted phosphoprotein-1 harnesses glial-, immune-, and neuronal cell ligand-receptor interactions to sense and regulate acute and chronic neuroinflammation","volume":"311","author":"Yim","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib86","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrc2345","article-title":"Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer","volume":"8","author":"Bellahc\u00e8ne","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib87","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cyto.2017.12.022","article-title":"Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3","volume":"109","author":"Murphy","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib89","article-title":"Atypical CXCL12 signaling enhances neutrophil migration by modulating nuclear deformability","volume":"15","author":"Cal\u00ec","year":"2025","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41467-025-56110-7","article-title":"A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation","volume":"16","author":"Tang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib91","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1021\/jacs.2c12986","article-title":"In situ separable nanovaccines with stealthy bioadhesive capability for durable cancer immunotherapy","volume":"145","author":"Yu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib92","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.1163612","article-title":"Different T cell receptor signals determine CD8+ memory versus effector development","volume":"323","author":"Teixeiro","year":"2009","journal-title":"Science (80)."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib93","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.actbio.2023.05.032","article-title":"Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy","volume":"166","author":"Dai","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib94","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1021\/jacs.2c12942","article-title":"MnOOH-Catalyzed autoxidation of glutathione for reactive oxygen species production and nanocatalytic tumor innate immunotherapy","volume":"145","author":"Zhu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib95","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/acsnano.1c10231","article-title":"A metabolic multistage glutathione depletion used for tumor-specific chemodynamic therapy","volume":"16","author":"Huang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2023.03.036","article-title":"STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications","volume":"357","author":"Xu","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120638","article-title":"Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy","volume":"269","author":"Xie","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.025_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102739","article-title":"An intelligent nanovehicle armed with multifunctional navigation for precise delivery of toll-like receptor 7\/8 agonist and immunogenic cell death amplifiers to eliminate solid tumors and trigger durable antitumor immunity","volume":"11","author":"Hao","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib99","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1038\/s41467-025-60927-7","article-title":"Engineering STING Nanoadjuvants for spatiotemporally-tailored innate immunity stimulation and cancer vaccination therapy","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41467-020-20243-8","article-title":"Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib101","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ni.3031","article-title":"Molecular regulation of effector and memory T cell differentiation","volume":"15","author":"Chang","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib102","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/s41467-022-30543-w","article-title":"Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis","volume":"13","author":"Guan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib103","article-title":"Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.025_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206851","article-title":"Biomineralized two-enzyme nanoparticles regulate tumor glycometabolism inducing tumor cell pyroptosis and robust antitumor immunotherapy","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:39:14Z","timestamp":1790408354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26002276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":104,"alternative-id":["S2452199X26002276"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.025","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSH-responsive nanovaccine triggers immunogenic cell death and potent memory T cell immunity for durable, recurrence-free tumor eradication","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}